Trastuzumab Completed Phase 2 Trials for Her2-Positive Breast Cancer / Male Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00077376Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer